i-SENS, Inc.

KOSDAQ 099190.KQ

i-SENS, Inc. Price to Book Ratio (P/B) on January 14, 2025: 1.37

i-SENS, Inc. Price to Book Ratio (P/B) is 1.37 on January 14, 2025, a -59.24% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

i-SENS, Inc. 52-week high Price to Book Ratio (P/B) is 3.37 on January 15, 2024, which is 145.37% above the current Price to Book Ratio (P/B).
i-SENS, Inc. 52-week low Price to Book Ratio (P/B) is 1.31 on December 30, 2024, which is -4.81% below the current Price to Book Ratio (P/B).
i-SENS, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 2.09.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

KOSDAQ: 099190.KQ

i-SENS, Inc.

CEO	Dr. Geun-Sig Cha
IPO Date	Jan. 30, 2013
Location	South Korea
Headquarters	43, Banpo-daero 28-gil
Employees	687
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years